## GEHC: GE HealthCare Technologies Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -0.6% below STRENGTH zone (3.0-6.0%); PEG 2.58 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($77.77)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Caldwell Trust Co Invests $1.53 Million in GE HealthCare Technologies Inc. $GEHC**
- Source: MarketBeat | 20251216T100827 | Somewhat-Bullish | Relevance: 100%
- Caldwell Trust Co has acquired a new stake of 20,678 shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) worth approximately $1.53 million during the second quarter. Other institutional investors, including Vanguard Group Inc., Dodge & Cox, and State Street Corp, have also significantly increased their positions in the company. GE HealthCare Technologies currently holds a "Moderate Buy" rating with a consensus target price of $87.09 among analysts.

**2. GE Healthcare issues $1.25 billion in senior notes**
- Source: MSN | 20251216T030842 | Neutral | Relevance: 100%
- GE Healthcare announced the issuance of $1.25 billion in senior notes across two tranches. The first tranche consists of $600 million notes due 2028 with a 4.900% interest rate, and the second tranche includes $650 million notes due 2035 with a 5.150% interest rate. The offering is expected to close on December 20, 2024, with net proceeds intended for general corporate purposes, including refinancing existing debt.

**3. GE HealthCare Technologies Inc. $GEHC Shares Acquired by National Bank of Canada FI**
- Source: MarketBeat | 20251215T102425 | Somewhat-Bullish | Relevance: 100%
- National Bank of Canada FI has significantly increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC), boosting its holdings by 133.3% to 899,693 shares. Other prominent institutional investors, such as Dodge & Cox and Norges Bank, also acquired substantial positions, bringing the total institutional ownership to approximately 82.06%. The company reported strong quarterly earnings, beating analyst estimates, and has a "Moderate Buy" consensus rating from analysts with an average target price of $87.09.

**4. Holocene Advisors LP Acquires 2,581,522 Shares of GE HealthCare Technologies Inc. $GEHC**
- Source: MarketBeat | 20251214T125120 | Bullish | Relevance: 100%
- Holocene Advisors LP significantly increased its stake in GE HealthCare Technologies Inc. by acquiring an additional 2,581,522 shares, bringing its total holdings to 4,027,352 shares, valued at approximately $298.3 million. This makes GE HealthCare the firm's 27th largest holding, representing about 0.88% of the company. Analysts have a "Moderate Buy" consensus on GEHC with a target price around $87.09, following recent strong quarterly results and a dividend announcement.

**5. Philips Bets On AI To See Inside Arteries With SpectraWAVE Buy**
- Source: Benzinga | 20251215T100916 | Neutral | Relevance: 65%
- Royal Philips announced its acquisition of SpectraWAVE, Inc., a medical imaging company, to expand its coronary intervention technologies by integrating AI-supported platforms. This acquisition will enhance Philips' intravascular imaging capabilities with tools like HyperVueTM and X1TM-FFR, improving diagnostics for minimally invasive cardiac procedures. The move aligns with Philips' commitment to AI-driven image-guided therapy, despite recent cautious guidance on its longer-term growth outlook.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-11 | Citigroup | $88 | $83 | +6% |
| 2025-12-11 | Jefferies | $105 | $95 | +11% |
| 2025-11-21 | BTIG | $87 | $87 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-11 | Citigroup | main | Neutral |
| 2025-12-11 | Jefferies | main | Buy |
| 2025-11-21 | BTIG | reit | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 11.4% (-0.2%)
- Blackrock Inc.: 8.0% (+1.9%)
- Dodge & Cox Inc.: 6.0% (+16.8%)
- Capital Research Glo: 5.5% (+25.0%)
- State Street Corpora: 4.3% (-0.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.58 signals overvaluation risk, limited margin of safety. Forward P/E 16.7x stretched relative to 8% growth. Quality metrics strong (ROE 24%). Analyst sentiment positive (2 raises, avg +8%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $37.6B |
| Beta | 1.24 |
| 52W Range | $57.65 - $94.80 |
| Short Interest | 3.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.58 |
| Forward P/E | 16.7 |
| Current P/E | 18.1 |
| YoY Growth | 8.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 1.9% to -0.6% (-2.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.6pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 55. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.62% (CS: 28) | Neutral |
| RSI_14 | 55.4 | Neutral |
| MACD Histogram | 0.10 | Bullish |
| vs SMA20 | 1.021x | Above |
| vs SMA50 | 1.068x | Above |
| vs SMA200 | 1.104x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $82.25
- **Stop Loss:** $77.77 (5.4% risk)
- **Target:** $86.73 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 223
- **Position Value:** $18,341.75
- **Portfolio %:** 18.34%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk positioning. VIX remains calm at 16.48 while breadth shows modest improvement to 52%, indicating neither euphoria nor distress. Mixed sectoral themes from energy weakness to AI expansion suggest stock-picking environment rather than broad directional moves.*

### Earnings

**Next:** 2026-02-12 (Est: $1.40)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.05 | $1.07 | +2.2% |
| 2025Q2 | $0.92 | $1.06 | +15.4% |
| 2025Q1 | $0.91 | $1.01 | +10.6% |
| 2024Q4 | $1.26 | $1.45 | +14.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*